Concord Biotech has informed that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025, inter alia, to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and six months period ended 30 September 2025.
The above information is a part of company’s filings submitted to BSE.